As of Dec 02
| -0.01 / -0.37%|
The 6 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 7.45, with a high estimate of 9.50 and a low estimate of 3.50. The median estimate represents a +175.92% increase from the last price of 2.70.
The current consensus among 7 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.